Chào mừng trở lại
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Tham gia Cointime
Đã có tài khoản?
Bấm vào "Đăng nhập " để đồng ý Điều khoản dịch vụ Cointime và xác nhận rằng Chính sách bảo mật Cointime là dành cho bạn.
Đăng nhập với email
Đăng nhập với
Email của bạn
Đăng ký
Bấm vào liên kết chúng tôi gửi tới để đăng nhập
Nhấp vào liên kết chúng tôi đã gửi tới để đăng ký.
Avraham Pharmaceuticals
company
About
Avraham Pharmaceuticals, a pharmaceutical company, develops novel products for the treatment and prevention of neurodegenerative disorders.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $4.50M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2010
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Avraham Pharmaceuticals (“Avraham”) is a privately held, emerging pharmaceutical company developing novel products for treatment and/or prevention of neurodegenerative disorders. Founded in 2010, Avraham has raised $9 million to conduct a European Phase II proof-of-concept efficacy trial in patients with Alzheimer's disease, supporting the development of its lead product candidate, ladostigil.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$4.50M
Avraham Pharmaceuticals has raised a total of
$4.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 17, 2014 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 17, 2014 | Series Unknown | $4.50M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Avraham Pharmaceuticals is funded by 1 investors.
Integra LifeSciences
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Integra LifeSciences
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
